A Randomized, Placebo-controlled Trial of DAPAgliflozin (DAPA) for Cardiovascular Risk Reduction in the Postpartum Period of Hypertensive Pregnancies (HP)

NCT06785116 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Gestational Hypertension
Hypertension in Pregnancy
Pre-Eclampsia
Superimposed Pre-Eclampsia
Cardiovascular Complication

Interventions

DRUG: Placebo
DRUG: Dapagliflozin 10mg Tab

Sponsor

University of Michigan

Collaborators

[object Object]
[object Object]